Trial Profile
Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2014
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 15 Jan 2010 Actual end date (September 2009) added as reported by ClinicalTrials.gov.
- 01 Jan 2010 Planned end date changed from 1 Aug 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
- 04 Nov 2009 Actual patient number (416) added as reported by ClinicalTrials.gov.